Related Experiment Video
Updated: May 14, 2026
18:08
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
Pharmacogenomics: where will it take us?
Biotechnology Healthcare
|February 12, 2013
Summary
Pharmacogenomics, or personalized medicine, uses genetic data to develop targeted drugs for specific patient groups. This approach represents an incremental but significant shift from traditional blockbuster drug discovery, promising tailored treatments over the next decades.
Area of Science:
- Genomics and Bioinformatics
- Pharmacology and Drug Discovery
- Translational Medicine
Background:
- Traditional drug research prioritizes blockbuster drugs for broad populations.
- The Human Genome Project catalyzed advancements in genetic understanding.
- Pharmacogenomics aims to revolutionize treatment through personalized approaches.
Purpose of the Study:
- To shift focus from blockbuster drugs to personalized medicine.
- To leverage genetic information for targeted drug development.
- To outline the future trajectory of pharmacogenomics.
Main Methods:
- Utilizing genetic information to elucidate disease pathways.
- Designing drugs tailored to specific patient subpopulations.
- Analyzing genetic data for drug response prediction.
Main Results:
- Identification of genetic markers for targeted drug development.
- Development of strategies for personalized treatment plans.
- Understanding of disease mechanisms at a genetic level.
Conclusions:
- Pharmacogenomics offers a pathway to personalized medicine.
- Drug development will increasingly incorporate genetic insights.
- Progress in personalized medicine will be incremental over the coming decades.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...